Quadrise advances with new strategic partnerships and testing program, hailed by broker

Quadrise plc
[shareaholic app="share_buttons" id_name="post_below_content"]

Quadrise Plc (LON:QED) was recently highlighted by Shore Capital in a report which discusses the recent developments involving Quadrise, BTG Bioliquids BV (BTL), and Euthenia Energy Group. Quadrise has been collaborating with BTL to investigate the potential of using BTL’s fast pyrolysis bio-oil (FPBO) for Quadrise’s bioMSAR fuel, resulting in positive outcomes and stable formulations. This advancement aligns with Quadrise’s goal to produce a net-zero biofuel by 2030.

Quadrise and BTL have entered into a Project Development Agreement with Euthenia, a company that focuses on renewable energy projects across Europe, North America, and the Caribbean. The agreement includes a series of lab and pilot tests, diesel engine testing, and plans for a commercial marine vessel trial. This collaboration aims to accelerate the development of sustainable fuels for the global shipping industry, particularly in the Mediterranean.

Additionally, Quadrise has partnered with Cargill, a significant renewable biofuels supplier, to produce fuels for marine vessel trials, notably on the MSC Leandra. This partnership is seen as promising due to Cargill’s extensive fleet and market presence, potentially generating significant revenues for Quadrise if MSC switches a portion of its fuel needs to Quadrise’s solutions.

Tom Fraine, Research Analyst at Shore Capital said, “We are encouraged to see another multinational company acknowledge Quadrise’s solutions for decarbonisation and commit to an agreement. This update follows the agreement announced earlier this  month  with  Cargill,  a  major  supplier  of  renewable  biofuels,  for  the production of Quadrise’s fuels for marine vessel trials on the MSC Leandra. We believe Cargill is a very attractive partner for Quadrise, which could lead to future opportunities, given Cargill’s own fleet of >500 vessels and considerable scale in global markets. 

Quadrise’s opportunity in the marine sector with MSC alone could be worth a multiple of its current  enterprise  value  in  potential  annual  revenues  if  only  small  percentage  of  the  shipping company’s overall fuel demand was switched to MSAR or bioMSAR. MSC currently consumes close to  10m  tonnes  of  fuel  oil  annually  and  we  believe  Quadrise  could  charge  c.$50  per  tonne  for licensing its technology.

The report highlights the efficiency, cost-effectiveness, and environmental benefits of Quadrise’s fuels compared to current marine fuels. It also touches on the broader industry and regulatory context, noting recent calls by shipping company CEOs for an end to fossil-fuel-powered vessels and urging regulatory support for green fuels, which Shore Capital think could further benefit Quadrise’s position in the market.

Share on:
Find more news, interviews, share price & company profile here for:

Transitional fuels provide a strategic decarbonisation path for shipping

Quadrise’s marine fuels offer shipping a cost-effective way to cut emissions today while preparing for tomorrow’s clean energy shift.

Quadrise Sustainability Report highlights progress in low-emission marine fuels

Quadrise plc announces the release of its Sustainability Report 2025, reporting a 21% reduction in operational emissions intensity, successful engine trials of MSAR® and bioMSAR™, and continued progress toward commercial deployment across shipping and international energy projects.

How shipping’s transition is reshaping investment strategy

Regulation, fuel strategy and finance are reshaping shipping, and creating clear opportunities for investors focused on the transition.

SEASTARS project moves to integration phase as Quadrise joins key assembly

Quadrise supports the SEASTARS project as it moves from R&D into real-world deployment.

Quadrise advances marine biofuel technology at key industry workshop

Quadrise presented its low-emission marine fuel technologies at a Washington workshop, highlighting commercial progress and positioning for future uptake.

Quadrise extends exclusive MSAR® and bioMSAR™ collaboration with Nouryon

Quadrise plc has renewed its Exclusive Global Collaboration and Emulsifiers Sales Agreement with Nouryon, extending the partnership until 31 October 2026.

Search

Search